abstract |
The disclosure herein is a novel compound of formula (1): TIFF2022504798000062.tif3080 and salts thereof (where R1, AA1, AA2, LysR, X and Y are as defined herein). , And their use in the treatment, prevention, amelioration, control or reduction of risk thereof for disorders associated with the glucagon-like peptide-1 (GLP-1) receptor. |